Progress and prospects: Human artificial chromosomes

Gene Therapy

Volumn 16, Issue 10, 2009, Pages 1180-1188

  Macnab, S ^a   Whitehouse, A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; DYSTROPHIN; GANCICLOVIR; GENE PRODUCT; GENOMIC DNA; PROTEIN FRDA; THYMIDINE KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

AMINO TERMINAL SEQUENCE; AMPLICON; ARTIFICIAL CHROMOSOME; ARTIFICIAL HYBRIDIZATION; BACTERIAL ARTIFICIAL CHROMOSOME; CARBOXY TERMINAL SEQUENCE; CELL BASED GENE THERAPY; DNA PURIFICATION; DUCHENNE MUSCULAR DYSTROPHY; ELECTROPHORESIS; GENE CONSTRUCT; GENE EXPRESSION; GENE LOCUS; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC TRANSFORMATION; GLIOMA; HERPES VIRUS SAIMIRI; HUMAN; IN VIVO STUDY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; TRANSGENE; TRANSPOSON; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; YEAST ARTIFICIAL CHROMOSOME;

CHROMOSOMES, ARTIFICIAL, HUMAN; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; STEM CELL TRANSPLANTATION; TRANSGENES;

EID: 70350200876     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.102     Document Type: Review

References (27)

1. Duncan A, Hadlaczky G. Chromosomal engineering. Curr Opin Biotechnol 2007; 18: 420-424.
2. Lufino MM, Edser PA, Wade-Martins R. Advances in highcapacity extrachromosomal vector technology: Episomal maintenance, vector delivery, and transgene expression. Mol Ther 2008; 16: 1525-1538.
3. Ren X, Tahimic CG, Katoh M, Kurimasa A, Inoue T, Oshimura M. Human artificial chromosome vectors meet stem cells: New prospects for gene delivery. Stem Cell Rev 2006; 2: 43-50.
4. Monaco ZL, Moralli D. Progress in artificial chromosome technology. Biochem Soc Trans 2006; 34: 324-327.
5. Heaney JD, Bronson SK. Artificial chromosome-based transgenes in the study of genome function. Mamm Genome 2006; 17: 791-807.
6. Peterson KR. Preparation of intact yeast artificial chromosome DNA for transgenesis of mice. Nat Protoc 2007; 2: 3009-3015.
7. Leem SH, Yoon YH, Kim SI, Larionov V. Purification of circular YACs from yeast cells for DNA sequencing. Genome 2008; 51: 155-158.
8. Kouprina N, Larionov V. Selective isolation of genomic loci from complex genomes by transformation-associated recombination cloning in the yeast Saccharomyces cerevisiae. Nat Protoc 2008; 3: 371-377.
9. Zhou F, Li Q, Gao SJ. A sequence-independent in vitro transposon-based strategy for efficient cloning of genomes of large DNA viruses as bacterial artificial chromosomes. Nucleic Acids Res 2008; 37: E2 (doi:10.1093/nar/gkn890).
10. Macnab S, White R, Hiscox J, Whitehouse A. Production of an infectious Herpesvirus saimiri-based episomally maintained amplicon system. J Biotechnol 2008; 134: 287-296.
11. Hibbitt OC, Harbottle RP, Waddington SN, Bursill CA, Coutelle C, Channon KM et al. Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection. J Gene Med 2007; 9: 488-497.
12. Griffiths RA, Boyne JR, Whitehouse A. Herpesvirus saimiribased gene delivery vectors. Curr Gene Ther 2006; 6: 1-15.
13. Grant KG, Krisky DM, Ataai MM, Glorioso III JC. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors. Biotechnol Bioeng 2008; 102: 1087-1097.
14. Moralli D, Simpson KM, Wade-Martins R, Monaco ZL. A novel human artificial chromosome gene expression system using herpes simplex virus type 1 vectors. EMBO Rep 2006; 7: 911-918.
15. Jiao W, Lin HM, Timmons J, Nagaich AK, Ng SW, Misteli T et al. E2F-dependent repression of topoisomerase II regulates heterochromatin formation and apoptosis in cells with melanomaprone mutation. Cancer Res 2005; 65: 4067-4077.
16. Ooi YS, Warburton PE, Ravin NV, Narayanan K. Recombineering linear DNA that replicate stably in E. coli. Plasmid 2008; 59: 63-71.
17. Roguev A, Krogan NJ. BAC to the future: Functional genomics in mammals. Nat Methods 2008; 5: 383-384.
18. Poser I, Sarov M, Hutchins JR, Heriche JK, Toyoda Y, Pozniakovsky A et al. BAC TransgeneOmics: A high-throughput method for exploration of protein function in mammals. Nat Methods 2008; 5: 409-415.
19. Kotzamanis G, Abdulrazzak H, Gifford-Garner J, Haussecker PL, CheungW, Grillot-Courvalin C et al. CFTR expression from a BAC carrying the complete human gene and associated regulatory elements. J Cell Mol Med 2008; 24 (Postprint; 10.1111/j.1582-4934.2008.00433.x).
20. Hibbitt OC, Wade-Martins R. Delivery of large genomic DNA inserts > 100 kb using HSV-1 amplicons. Curr Gene Ther 2006; 6: 325-336.
21. Gomez-Sebastian S, Gimenez-Cassina A, Diaz-Nido J, Lim F, Wade-Martins R. Infectious delivery and expression of a 135 kb human FRDA genomic DNA locus complements Friedreich's ataxia deficiency in human cells. Mol Ther 2007; 15: 248-254.
22. Shitara S, Kakeda M, Nagata K, Hiratsuka M, Sano A, Osawa K et al. Telomerase-mediated life-span extension of human primary fibroblasts by human artificial chromosome (HAC) vector. Biochem Biophys Res Commun 2008; 369: 807-811.
23. Hoshiya H, Kazuki Y, Abe S, Takiguchi M, Kajitani N, Watanabe Y et al A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 MB entire human dystriophin gene. Mol Ther 2008; 17: 309-317.
24. Hoen P, de Meijer E, Boer J, Vossen R, Turk R, Maatman R et al. Generation and characterization of transgenic mice with the fulllength human DMD gene. J Biol Chem 2008; 283: 5899-5907.
25. Kinoshita Y, Kamitani H, Mamun M, Wasita B, Kazuki Y, Hiratsuka M et al. A gene delivery system with a human artificail chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells. Neurol Res 2009 (doi:10.1179/174313209X455718).
26. Katona R, Sinko I, Hollo G, Szucs K, Praznoszky T, Kereso J et al. A combined artificialchromosome-stem cell therapy method in a model experiment aimed at the treatment of Krabbe's disease in the Twitcher mouse. Cell Mol Life Sci 2008; 65: 3830-3838.
27. Kazuki Y, Hoshiya H, Kai Y, Abe S, Takiguchi M, Osaki M et al. Correction of a genetic defect in multipotent germline stem cells using a human artifical chromosome. Gene Therapy 2008; 15: 617-624.